Abstract
Ginseng has been used in the Orient for several thousand years as an ‘adaptogenic’ as well as a ‘restorative’ agent. It has been used to treat nervous disorders, anaemia, wakefulness, dyspnoea, forgetfulness and confusion, prolonged thirst, decreased libido, chronic fatigue, angina and nausea. Although the mechanisms underlying the alleged effects of ginseng remain to be elucidated, there is an extensive animal literature dealing with the effects of ginseng on the cardiovascular system, central nervous system, endocrine system, metabolism, and immune system. In our previous review dealing with the efficacy of ginseng, we concluded that while studies with animals show that ginseng, or its active components, may prolong survival to physical or chemical stress, there is generally a lack of controlled research demonstrating the ability of ginseng to improve or prolong performance in fatigued humans. In this review, we extend our earlier analysis on the potential efficacy of ginseng use in the enhancement of physical performance and modification of fatigue states. Our analysis reveals that published literature appearing since our earlier review has not resolved the equivocal nature of research evidence involving animals or humans. Also, the lack of unanimity in this research can be explained on the basis of various methodological problems such as inadequate sample size and lack of double-blind, control and placebo paradigms. In addition, the absence of acceptable approaches to the problem of ‘sourcing’, in concert with an absence of compliance data in human research, further complicates the interpretation of this research literature. Nevertheless, the use of ginseng continues to grow, and current sales are estimated to be over $US300 million annually. There is clearly a need for systematic research dealing with the efficacy of ginseng, and this research needs to take into account basic, fundamental design considerations if there is to be any hope of establishing whether or not ginseng possesses efficacy.
Similar content being viewed by others
Notes
G115 is the registered trademark of a ginseng extract containing all 13 ginsenosides from the Korean Panax ginseng. This extract is marketed as Ginsana (GPL Ginsana Products SA, Lugano, Switzerland).
References
Horowitz B. Tea maker’s herbal addition: firm trying to supplement sales. USA Today 1998 April 14; 4B
Marwick C. Growing use of medicinal botanicals forces assessment by drug regulators. JAMA 1995; 273 (8): 607–9
Miller LG. Herbal medicinals. Arch Intern Med 1998; 158 (20): 2200–11
Richman A, Witkowski J. Herbs by the numbers. Whole Foods Magazine 1997; 20, 22, 24, 26, 28
Hellmich N. Herbal remedies take root, flourish. USA Today 1998 Dec 29; 6D
Deveny K. Garlic pills are potent drugstore sellers. Wall Street J 1992 Oct 1; B1, B14
Goldstein B. Ginseng: its history, dispersion, and folk tradition. Am J Chin Med 1975; 3 (3): 223–34
Hu SY. A contribution to our knowledge of ginseng. Am J Chin Med 1977; 5 (1): 1–23
Liu C-X, Xiao P-G. Recent advances in ginseng research in China. J Ethnopharmacol 1992; 36: 27–38
Brekhman II, Dardymov IV. New substances of plant origin which increase nonspecific resistance. Annu Rev Pharmacol 1969; 9: 419–30
Cartwright L. Ginseng in pharmacies. Aust J Pharm 1979; 60: 346–9
Hu SY. The genus Panax (ginseng) in Chinese medicine. Econ Botany 1976; 30: 11–28
Li CP, Li RC. An introductory note to ginseng. Am J Chin Med 1973; 1 (2): 249–61
Perry LM, Metzger J. Medicinal plants of east and southeast asia: attributed properties and uses. Cambridge (MA): MIT Press, 1980
Baranov A. Recent advances in our knowledge of the morphology, cultivation and uses of ginseng (Panax ginseng C.A. Meyer). Econ Botany 1966; 20: 403–6
Bittles AH, Fulder SJ, Grant EC, et al. The effect of ginseng on lifespan and stress responses in mice. Gerontology 1979; 25: 125–31
Popov IM, Goldwag WJ. A review of the properties and clinical effects of ginseng. Am J Chin Med 1973; 1 (2): 263–70
Phillipson JD, Anderson LA. Ginseng: quality, safety, and efficacy? Pharm J 1984; 232: 161–5
Bahrke MS, Morgan WP. Evaluation of the ergogenic properties of ginseng. Sports Med 1994; 18 (4): 229–48
Pietta P, Mauri P, Rava A. Improved high-performance liquid chromatographic method for the analysis of ginsenosides in Panax ginseng extracts and products. J Chromatogr 1986; 356: 212–9
Barna P. Food or drug? The case of ginseng [letter]. Lancet 1985; II: 548
Court WE. Ginseng: a Chinese folk medicine of current interest. Pharm J 1975; 214: 180–1
Williams LO. Ginseng. Econ Botany 1957; 11: 344–8
Baranov AI. Medicinal uses of ginseng and related plants in the Soviet Union: recent trends in the Soviet literature. J Ethnopharmacol 1982; 6: 339–53
Brekhman II. Eleutherococcus senticosus: a new medicinal herb of the araliaceae family. In: Chen KK, Mukerji B, editors. Pharmacology of oriental plants. New York (NY):Macmillan Company, 1965: 97–102
Liberti LE, Der Marderosian A. Evaluation of commercial ginseng products. J Pharm Sci 1978; 67 (10): 1487–9
Hou JP. The chemical constituents of ginseng plants. Comp Med East West 1977; 5 (2): 123–45
Iwabuchi H, Yoshikura M, Ikawa Y, et al. Studies on the sesquiterpenoids of Panax ginseng C.A.Meyer: isolation and structure determination of sesquiterpene alcohols, panasinsanols A and B. Chem Pharm Bull 1987; 35 (5): 1975–81
Iwabuchi H, Yoshikura M, KamisakoW. Studies on the sesquiterpenoids of Panax ginseng C.A. Meyer II: isolation and structure determination of ginsenol, a novel sesquiterpene alcohol. Chem Pharm Bull 1988; 36 (7): 2447–51
Kasai R, Yamaguchi H, Tanaka O. High-performance liquid chromatography of glycosides on a new type of hydroxyapatite column. J Chromatogr 1987; 407: 205–10
Shibata S, Fujita M, Itokawa H, et al. Studies on the constituents of Japanese and Chinese crude drugs: XI. Panaxadiol, a sapogenin of ginseng roots. Chem Pharm Bull 1963; 11 (6): 759–61
Tanaka O, Nagai M, Shibata S. Chemical studies on the Oriental plant drugs: XVI. The stereochemistry of protopanaxadiol, a genuine sapogenin of ginseng. Chem Pharm Bull 1966; 14 (10): 1150–6
Yamaguchi H, Kasai R, Matsuura H, et al. High-performance liquid chromatographic analysis of acidic saponins of ginseng and related plants. Chem Pharm Bull 1988; 36 (9): 3468–73
Iida Y, Tanaka O, Shibata S. Studies on saponins of ginseng: the structure of ginsenoside-Rg1. Tetrahedron Lett 1968; 52: 5449–53
Shibata S, Tanaka O, Soma K, et al. Studies on saponins and sapogenins of ginseng: the structure of panaxatriol. Tetrahedron Lett 1965; 3: 207–13
Besso H, Kasai R, Wei J, et al. Further studies on dammaranesaponins of American ginseng, roots of Panax quinquefolium L. Chem Pharm Bull 1982; 30 (12): 4534–8
Elyakov GB, Strigina LI, Uvarova NI, et al. Glycosides from ginseng roots. Tetrahedron Lett 1964; 48: 3591–7
Petkov VD, Yinglin C, Todorov I, et al. Behavioral effects of stem-leaves extract from Panax ginseng C.A. Meyer. Acta Physiol Pharmacol Bulg 1992; 18 (2): 41–8
Chong SKF, Oberholzer VG. Ginseng: is there a use in clinical medicine? Postgrad Med J 1988; 64: 841–6
Matsuda H, Namba K, Fukuda S, et al. Pharmacological study on Panax ginseng C.A. Meyer: III. Effects of red ginseng on experimental disseminated intravascular coagulation. (2). Effects of ginsenosides on blood coagulative and fibrinolytic systems. Chem Pharm Bull 1986; 34 (3): 1153–7
Mattei R, Dias RF, Espinola EB, et al. Guarana (Paullinia cupana): toxic behavioral effects in laboratory animals and antioxidant activity in vitro. J Ethnopharmacol 1998; 60 (2): 111–6
Wang LCH, Lee T-F. Effect of ginseng saponins on exercise performance in non-trained rats. Planta Med 1998; 64: 130–3
Grandhi A, Mujumdar AM, Patwardhan B. A comparative pharmacological investigation of Ashwagandha and ginseng. J Ethnopharmacol 1994; 44 (3): 131–5
Nitta H, Matsumoto K, Shimizu M, et al. Panax ginseng extract improves the performance of aged Fischer 344 rats in radial maze task but not in operant brightness discrimination task. Biol Pharm Bull 1995; 18 (9): 1286–8
Huong NTT, Matsumoto K, Yamasaki K, et al. Crude saponin extracted from Vietnamese ginseng and its major constituent majonoside-R2 attenuate the psychological stress- and foot-shock stress-induced antinociception in mice. Pharmacol Biochem Behav 1995; 52 (2): 427–32
Sorensen H, Sonne J. A double-masked study of the effects of ginseng on cognitive functions. Curr Ther Res 1996; 57 (12): 959–68
Wesnes KA, Faleni RA, Hefting NR, et al. The cognitive, subjective, and physical effects of a Ginko biloba/Panax ginseng combination in healthy volunteers with neurasthenic complaints. Psychopharmacol Bull 1997; 33 (4): 677–83
Thommessen B, Laake K. Ginseng: no identifiable effect in geriatric rehabilitation. Tidsskr Nor Laegeforen 1997; 117 (26): 3839–41
Smith K, Engels H-J, Martin J, et al. Efficacy of a standardized ginseng extract to alter psychological function characteristics at rest and during exercise stress [abstract]. Med Sci Sports Exerc 1995; 27 (5) Suppl.: S147
Marasco A, Ruiz R, Villagomez A, et al. Double-blind study of a multivitamin complex supplemented with ginseng extract. Drugs Exp Clin Res 1996; 22 (6): 323–9
Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 1995; 18 (10): 1373–5
Han KH, Choe SC, Kim HS, et al. Effect of red ginseng on blood pressure in patients with essential hypertension and white coat hypertension. Am J Chin Med 1998; 26 (2): 199–209
Macaraeg PVJ, Ramos E. The effect of ginseng on exercise duration [abstract]. The XXIII FIMS World Congress of Sports Medicine Abstracts 1986. Champaign (IL): Fédération Internationale de Médicine Sportive, 1986: 151
Ng CC, Ng YK. The effect of ginseng: a traditional Chinese medicine on physical capacity [abstract]. The XXIII FIMS World Congress of Sports Medicine Abstracts 1986. Champaign (IL): Fédération Internationale de Médicine Sportive, 1986: 196
McNaughton L, Egan G, Caelli G. A comparison of Chinese and Russian ginseng as ergogenic aids to improve various facets of physical fitness. Int Clin Nutr Rev 1989; 9 (1): 32–5
Gribaudo CG, Ganzit GP, Verzini EF. Effetti sulla forza e sulla fatica muscolare di un prodotto ergogenico di origine naturale. Med Dello Sport 1990; 43 (4): 241–9
Gribaudo CG, Ganzit GP, Biancotti PP, et al. Effetti della somministrazione di un prodotto naturale ergogenico sulle doti aerobiche di ciclisti agonisti. Med Dello Sport 1991; 44 (4): 335–43
Morris AC, Jacobs I, McLellan TM, et al. No ergogenic effect of ginseng ingestion. Int J Sport Nutr 1996; 6: 263–71
Lifton B, Otto RM, Wygand J. The effect of ginseng on acute maximal aerobic exercise [abstract]. Med Sci Sports Exerc 1997; 29 (5) Suppl.: S249
Allen JD, McLung J, Nelson AG, et al. Ginseng supplementation does not enhance healthy young adults’ peak aerobic exercise performance. J Am Coll Nutr 1998; 17 (5): 462–6
Engels H-J, Said JM, Wirth JC. Failure of chronic ginseng supplementation to affect work performance and energy metabolism in healthy adult females. Nutr Res 1996; 16 (8): 1295–305
Engels H-J, Said J, Wirth JC, et al. Effect of chronic ginseng intake on metabolic responses during and in the recovery from graded maximal exercise [abstract]. Med Sci Sports Exerc 1995; 27 (5) Suppl.: S147
Engels H-J, Feng S, Chen Y. Effect of ginseng (G115) on maximal aerobic exercise performance in aerobically fit young adults [abstract]. The XXVI FIMS World Congress of Sports Medicine Abstracts 1998; Champaign (IL): Fédération Internationale de Médicine Sportive, 1998: 33
Engels H-J, Wirth JC. No ergogenic effects of ginseng (Panax Ginseng C.A. Meyer) during graded maximal aerobic exercise [abstract]. Int J Sport Nutr 1998; 8: 202
Kolokouri I, Engels H-J, Cieslak T, et al. Effect of chronic ginseng supplementation on short duration, supramaximal exercise test performance [abstract]. Med Sci Sports Exerc 1999; 31 (5) Suppl.: S117
Asano K, Takahashi T, Miyashita M, et al. Effect of Eleutheroccocus senticosus extract on human physical working capacity. Planta Med 1986; 3: 175–7
Dowling EA, Redondo DR, Branch JD, et al. Effect of Eleutherococcus senticosus on submaximal and maximal exercise performance. Med Sci Sports Exerc 1996; 28 (4): 482–9
Eschbach LC, Webster MJ, Boyd JC, et al. The effect of Eleutherococcus senticosus (Siberian ginseng) on substrate utilization and performance during prolonged cycling [abstract]. Med Sci Sports Exerc 1999; 31 (5) Suppl.: S117
Morgan WP. Methodological considerations. In: Morgan WP, editor. Physical activity and mental health. Washington, DC: Taylor and Francis, 1997: 3–32
Siegel RK. Ginseng abuse syndrome: problems with the panacea. JAMA 1979; 241 (15): 1614–5
Klepser TB, Klepser ME. Unsafe and potentially safe herbal therapies. Am J Health Syst Pharm 1999; 56: 125–38
Ryu S-J, Chien Y-Y. Ginseng-associated cerebral arteritis. Neurology 1995; 45: 829–30
Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 1997; 54: 692–3
Sirdofsky M, Kattah J, Macedo P. Intracranial hypertension in a dieting patient. J Neurol Ophthalmol 1994; 14 (1): 9–11
Baldwin CA, Anderson LA, Phillipson JD. What pharmacists should know about ginseng. Pharm J 1986; 237: 583–6
Owen RT. Ginseng: a pharmacological profile. Drugs Today 1981; 17: 343–51
Johnston BA. One-third of nation’s adults use herbal remedies. Herbalgram 1997; 40: 49
Li TSC, Mazza G, Cottrell AC, et al. Ginsenosides in roots and leaves of American ginseng. J Agric Food Chem 1996; 44 (3): 717–20
Smith RG, Caswell D, Carriere A, et al. Variation in the ginsenoside content of American ginseng, Panax quinquefolius Lroots. Can J Bot 1996; 74: 1616–20
Vigano C, Ceppi E. What is in ginseng [letter]? Lancet 1994; 344 (8922): 619
Walker AF. What is in ginseng [letter]? Lancet 1994; 344 (8922): 619
Awang DVC. Siberian ginseng toxicity may be case of mistaken identity [letter]. Can Med J 1996; 155 (9): 1237
Bahrke MS. Ginseng: a root just like a carrot [letter]. J R Soc Med 1995; 88: 304
Bahrke MS. Comments on ‘Manic episode and ginseng: report of a possible case’ [letter]. J Clin Psychopharmacol 1997; 17 (2): 140–1
Becker BN, Greene J, Evanson J, et al. Ginseng-induced diuretic resistance [letter]. JAMA 1996; 276 (8): 606–7
Chosidow O, Dega H, Peytavin G. Authors’ reply [letter]. Lancet 1996; 348: 267
Dega H, Laporte J-L, Frances C, et al. Ginseng as a cause for Stevens-Johnson syndrome [letter]? Lancet 1996; 347: 1344
Faleni R, Soldati F. Ginseng as cause of Stevens-Johnson syndrome [letter]? Lancet 1996; 348: 267
Gonzalez-Seijo JC, Ramos YM, Lastra I. Manic episode and ginseng: report of a possible case [letter]. J Clin Psychopharmacol 1995; 15 (6): 447–8
Huxtable RJ. The myth of beneficent nature: the risks of herbal preparations. Ann Intern Med 1992; 117: 165–6
Hammond TG, Whitworth JA. Adverse reactions to ginseng [letter]. Med J Aust 1981 May 2; 492
McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. Can Med Assoc J 1996; 155 (3): 293–5
Wilkie A, Cordes C. Ginseng: a root just like a carrot [letter]? J R Soc Med 1994; 87 (10): 594–5
Cui J-F. Identification and quantification of ginsenosides in various commercial ginseng preparations. Euro J Pharm Sci 1995; 3 (2): 77–85
Cui J-F, Garle M, Bjokhem I, et al. Determination of aglycones of ginsenosides in ginseng preparations sold in Sweden and in urine samples from Swedish athletes consuming ginseng. Scand J Clin Lab Invest 1996; 56: 151–60
Vaughan MA, Doolittle RL, Gennett T, et al. Physiological effects of ginseng may be due to methylxanthines [abstract]. Med Sci Sports Exerc 1999; 31 (5) Suppl.: S121
Matsunaga H, Katano M, Yamamoto H, et al. Cytotoxic activity of polyacetylene compounds in Panax ginseng C.A. Meyer. Chem Pharm Bull 1990; 38: 3480–2
Madison WI. Officials question purity of ginseng: regulators find use of illegal pesticides. Capital Times 1997 Oct 7
Cable News Network. Company says ginseng batch contaminated [online]. Available from: http://cnn.com/HEALTH/9805/21/tainted.ginseng/index.html [Accessed 1999 Dec 15]
Ginseng warning. USA Today 1997 Dec 19; 3A
Watt J, Bottomly MB, Read MTF. Olympic athletics medical experience. Seoul: personal views. Br J Sports Med 1989; 23 (2): 76–9
Fuentes RJ, Rosenberg JM, Davis A, editors. Athletic drug reference. Durham (NC): Clean Data Inc., 1996
Gillis CN. Panax ginseng pharmacology: a nitric oxide link? Biochem Pharmacol 1997; 54 (1): 1–8
Trine MR. Physical activity and quality of life. In: Rippe JM, editor. Lifestyle medicine. Malden (MA): Blackwell Scientific Publications, 1999: 989–99
Wiklund I, Karlberg J, Lund B. A double-blind comparison of the effect on quality of life of a combination of vital substances including standardized ginseng G115 and placebo. Curr Ther Res 1994; 55 (1): 32–42
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bahrke, M.S., Morgan, W.P. Evaluation of the Ergogenic Properties of Ginseng. Sports Med 29, 113–133 (2000). https://doi.org/10.2165/00007256-200029020-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00007256-200029020-00004